Emerging Hepatitis C Treatment Strategies For Difficult‐to‐Cure Patients

Emerging Hepatitis C Treatment Strategies For Difficult‐to‐Cure Patients

Faculty: Mark S. Sulkowski, MD, Tram T. Tran, MD, Paul Kwo, MD and Fred Poordad, MD
Release Date: November 12, 2016

Sadly not everyone who treats hepatitis C is cured, over at Practice Point those difficult to cure patients are discussed in a new learning activity. Although this video/lecture is aimed at clinicians, the use of clinical vignettes or patient-related cases and scenarios provides a somewhat patient friendly program.

Program

Welcome and Introductions - Mark S. Sulkowski, MD

HCV in Cirrhotics - Tram T. Tran, MD
Renal Considerations in HCV - Paul Kwo, MD
HCV Resistance Testing - Fred Poordad, MD
Closing Remarks - Mark S. Sulkowski

Sit back and watch a panel of renowned HCV experts discuss the following topics;

1. Review recent updates and changes to AASLD-IDSA recommendations for testing, managing, and treating hepatitis C
2. Discuss the efficacy of various DAA regimens in patients who have failed prior DAA therapies
3. Describe the efficacy and safety of different DAA regimens in the new difficult-to-cure patients

Register here. After a free quick registration, begin here.

View additional HCV learning activities and research articles; https://hepatitiscnewdrugs.blogspot.com/search/label/HCV-Education